At the genetic level, there have been no reports of point mutations that cause IRF-1 inactivation in breast cancer; however, an IRF-1 polymorphism (A4396G) has been identified in breast cancer cell lines, and has been found to be more frequent amongst African Americans [86]. The gene discussed is IRF1; the disease is breast cancer.